James Stygall

Statistics

Publications

Citations

114

H-Index

Active since

2001

Affiliations

Sanofi (France)(Current)

James Stygall is an author at Sanofi (France) specializing in neuropharmacology, neurodegenerative disease pharmacology, and neurodegenerative disease pharmacotherapy.

Publications per year

2001–2001

Publications

RPR 119990, a novel alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid antagonist: synthesis, pharmacological properties, and activity in an animal model of amyotrophic lateral sclerosis.

Thierry Canton, Böhme Ga, Alain Boireau et al. · PubMed · 2001 · 68 citations

Medicine, Neuroscience, Pharmacology +17

RPR 119990, a Novel α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Antagonist: Synthesis, Pharmacological Properties, and Activity in an Animal Model of Amyotrophic Lateral Sclerosis

Thierry Canton, Georg Andrees Böhme, Alain Boireau et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 46 citations

Medicine, Neuroscience, Pharmacology +12

1–2 of 2